SCHEMBL28515674

SCHEMBL28515674

COc1cc(OC)c2c(C(=O)O)c(C(=O)O)nn2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
TP53 P04637 1/20 0.36
USP2 O75604 2/20 0.36
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 3/20 0.35
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 1/20 0.35
ATM Q13315 1/20 0.34
ALPL P05186 1/20 0.34
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29870706 0.82 ALDH1A1 (0.40) ALDH1A1KMT2AUSP2CYP3A4MAPK1
SCHEMBL28528322 0.75 CA12 (0.49) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL22479275 0.72 IRAK4 (0.40) ALDH1A1KMT2ASMN1; SMN2KDM4EMAPT
SCHEMBL28391572 0.71 MEN1 (0.40) KMT2ACA12CA1CA2CA7
SCHEMBL28521561 0.71 RPA1 (0.40) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL20874144 0.69 MTNR1A (0.35) KMT2ATP53SMN1; SMN2KDM4ERPA1
SCHEMBL466144 0.69 CYP3A4 (0.60) KMT2ACA12CA1CA2CA7
SCHEMBL20874132 0.68 KMT2A (0.34) KMT2ACA12CA1CA2CA7
SCHEMBL28623498 0.66 KMT2A (0.47) ALDH1A1KMT2ACA12CA1CA2
SCHEMBL362125 0.65 ALDH1A1 (0.44) ALDH1A1KMT2ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074522-B Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation 深圳信立泰药业股份有限公司 2022-08-26 CN disclosed
CN-112074522-A Compounds as protease activated receptor 4(PAR4) inhibitors for the treatment of platelet aggregation 深圳信立泰药业股份有限公司 2020-12-11 CN disclosed